|
KTA0002
|
Annexin V-AbFluor™ 488/PI Apoptosis Detection kit
|
Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients(KTA0002-3)
|
3 |
Journal of Receptors and Signal |
|
A25222
|
IPKine™ HRP, Goat Anti-Rabbit IgG HCS
|
Improved in situ characterization of protein complex dynamics at scale with thermal proximity co-aggregation(A25222-15.7)
|
15.7 |
Int. J. Mol. Sci |
|
A01010
|
|
Improvement Activity of 1-Deoxynojirimycin in the Growth of Dairy Goat Primary Mammary Epithelial Cell through Upregulating LEF-1 Expression(A01010-2)
|
2 |
BioMed Research International |
|
KTE6011
|
EliKine™ Human IFN-γ ELISA Kit
|
In human CD4+ T-Cells, omeprazole suppresses proliferation, downregulates V-ATPase, and promotes differentiation toward an autoimmunity-favoring phenotype.(KTE6011-4.7)
|
4.7 |
International Immunopharmacology |
|
A23220
|
Dylight 488, Goat Anti-Rabbit IgG
|
Improvement of bone formation by bionic hydroxyapatite nanorod via the regulation of macrophage polarization(A23220-11)
|
11 |
Journal of Materials Science & Technology |
|
A23210
|
DyLight 488, Goat Anti-Mouse IgG
|
Improvement of bone formation by bionic hydroxyapatite nanorod via the regulation of macrophage polarization(A23210-11)
|
11 |
Journal of Materials Science & Technology |
|
KTE6015
|
EliKine™ Human IL-4 ELISA Kit
|
In human CD4+ T-Cells, omeprazole suppresses proliferation, downregulates V-ATPase, and promotes differentiation toward an autoimmunity-favoring phenotype.(KTE6015-4.7)
|
4.7 |
International Immunopharmacology |
|
KTE6019
|
EliKine™ Human IL-10 ELISA Kit
|
In human CD4+ T-Cells, omeprazole suppresses proliferation, downregulates V-ATPase, and promotes differentiation toward an autoimmunity-favoring phenotype.(KTE6019-4.7)
|
4.7 |
International Immunopharmacology |
|
KTE6022
|
EliKine™ Human IL-17 ELISA Kit
|
In human CD4+ T-Cells, omeprazole suppresses proliferation, downregulates V-ATPase, and promotes differentiation toward an autoimmunity-favoring phenotype.(KTE6022-4.7)
|
4.7 |
International Immunopharmacology |
|
A23210
|
DyLight 488, Goat Anti-Mouse IgG
|
In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy(A23210-15.7)
|
15.7 |
Stem Cell Research & Therapy |
